{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:23:48Z","timestamp":1760016228325},"reference-count":15,"publisher":"The Japanese Society for Medical Mycology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3314\/mmj.19-00016","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T17:12:43Z","timestamp":1582909963000},"page":"11-13","source":"Crossref","is-referenced-by-count":7,"title":["Antifungal Susceptibility of Clinical Isolates and Artificially Produced Multi-azole-resistant Strains of &lt;i&gt;Cryptococcus neoformans&lt;\/i&gt; (formerly: &lt;i&gt;Cryptococcus grubii&lt;\/i&gt;) to Ravuconazole"],"prefix":"10.3314","volume":"61","author":[{"given":"Rui","family":"Kano","sequence":"first","affiliation":[{"name":"Department of Veterinary Pathobiology, Nihon University College of Bioresouce Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kamata","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, Nihon University College of Bioresouce Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","unstructured":"1) Sykes JE and Malik R: Cryptococcosis. <i>In<\/i> Infectious Diseases of Dog and Cat (Green CE, ed) 4th ed, pp. 621-634, Elsevier Saunders, St. Louis, 2012."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Reiss E, Shadomy HJ, Lyon GMIII: Cryptococcosis. <i>In<\/i> Fun-damental Medical Mycology, pp. 303-331, Wiley-Blackwell, New Jersey, 2012.","DOI":"10.1002\/9781118101773"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kano R, Nakamura Y, Watari T, Tsujimoto H, Hasegawa A: A case of feline cryptococcosis treated with itraconazole. Mycoses 40: 381-383, 1997.","DOI":"10.1111\/j.1439-0507.1997.tb00255.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kano R, Fujino Y, Takamoto N, Tsujimoto H, Hasegawa A: PCR detection of the <i>Cryptococcus neoformans CAP59<\/i> gene from a biopsy specimen from a case of feline cryptococcosis. J Vet Diagn Invest 13: 439-442, 2001.","DOI":"10.1177\/104063870101300516"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Okabayashi K, Kano R, Watanabe T, Hasegawa A: Serotypes and mating types of clinical isolates from feline cryptococcosis in Japan. J Vet Med Sci 68: 91-94, 2006.","DOI":"10.1292\/jvms.68.91"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kano R, Okubo M, Yanai T, Hasegawa A, Kamata H: First Isolation of azole-resistant <i>Cryptococcus neoformans<\/i> from feline cryptococcosis. Mycopathologia 180: 427-433, 2015.","DOI":"10.1007\/s11046-015-9919-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Rodero L, Mellado E, Rodriguez AC, Salve A, Guelfand L, Cahn P, Cuenca-Estrella M, Davel G, Rodriguez-Tudela JL: G484S amino acid substitution in lanosterol 14-alpha demethylase (<i>ERG11<\/i>) is related to fluconazole resistance in a recurrent <i>Cryptococcus neoformans<\/i> clinical isolate. Antimicrob Agents Chemother 47: 3653-3656, 2003.","DOI":"10.1128\/AAC.47.11.3653-3656.2003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Smith KD, Achan B, Hullsiek KH, McDonald TR, Okagaki LH, Alhadab AA, Akampurira A, Rhein JR, Meya DB, Boulware DR, Nielsen K; ASTRO-CM\/COAT Team: Increased antifungal drug resistance in clinical isolates of <i>Cryptococcus neoformans<\/i> in Uganda. Antimicrob Agents Chemother 59: 7197-7204, 2015.","DOI":"10.1128\/AAC.01299-15"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Chen YC, Chang TY, Liu JW, Chen FJ, Chien CC, Lee CH, Lu CH: Increasing trend of fluconazole-non-susceptible <i>Cryptococcus neoformans<\/i> in patients with invasive cryptococcosis: a 12-year longitudinal study. BMC Infect Dis 15: 277, 2015.","DOI":"10.1186\/s12879-015-1023-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kano R, Okubo M, Hasegawa A, Kamata H: Multi-azole-resistant strains of <i>Cryptococcus neoformans<\/i> var. <i>grubii<\/i> isolated from a FLZ-resistant strain by culturing in medium containing voriconazole. Med Mycol 55: 877-882, 2017.","DOI":"10.1093\/mmy\/myw101"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fung-Tomc JC, Huczko E, Minassian B, Bonner DP: <i>In vitro<\/i> activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob Agents Chemother 42: 313-318, 1998.","DOI":"10.1128\/AAC.42.4.993"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yamazumi T, Pfaller MA, Messer SA, Houston A, Hollis RJ, Jones RN: <i>In vitro<\/i> activities of ravuconazole (BMS207147) against 541 clinical isolates of <i>Cryptococcus neoformans<\/i>. Antimicrob Agents Chemother 44: 2883-2886, 2009.","DOI":"10.1128\/AAC.44.10.2883-2886.2000"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Shalini K, Kumar N, Drabu S, Sharma PK: Advances in synthetic approach to and antifungal activity of triazoles. Beilstein J Org Chem 7: 668-677, 2011.","DOI":"10.3762\/bjoc.7.79"},{"key":"14","unstructured":"14) Clinical Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard, 3rd ed, CLSI document M27-A3, CLSI, Wayne, PA, 2008."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Cant&oacute;n E, Espinel-Ingroff A, Pem&aacute;n J: Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev Anti Infect Ther 7: 107-119, 2009.","DOI":"10.1586\/14787210.7.1.107"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/61\/1\/61_19-00016\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T22:13:51Z","timestamp":1582928031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/61\/1\/61_19-00016\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.19-00016","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}